TCF4-driven cathepsin S promotes papillary thyroid carcinoma via PI3K/AKT/mTOR
Endocrine-Related Cancer · 2026
DOI: 10.1530/erc-25-0517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2026. Verfasst von Xinyi Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Yancheng Clinical College of Xuzhou Medical University , Yancheng, China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Transcription Factor 4, Cathepsins, Thyroid Cancer, Papillary. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Papillary thyroid carcinoma (PTC) usually has a good prognosis, but lacks effective molecular biomarkers and therapeutic targets. However, a subset of patients develops lymph node metastasis, radioiodine resistance, and recurrence. Cathepsin S (CTSS), a lysosomal cysteine protease, has been implicated in several malignancies, yet its role and regulation in PTC remain unclear. We integrated GEO and TCGA-THCA datasets with eQTL-based genetic instrument analyses to screen PTC-related genes and evaluate their association with clinicopathological features and DFS. CTSS expression was examined in clinical tissues and cell lines by immunohistochemistry, RT-qPCR, and western blotting. Gain- and loss-of-function models were used to assess the effects of CTSS on PTC cell proliferation, colony formation, migration, apoptosis, and nude-mouse tumor growth. RNA-seq and TCGA pathway-score correlation analysis were used to explore downstream pathways, and transcriptional regulation was investigated by in silico prediction, ChIP-qPCR, and dual-luciferase assays. CTSS emerged as a candidate gene associated with PTC occurrence, lymph node metastasis, and shorter DFS. CTSS was markedly upregulated in PTC tissues and cell lines. Functionally, CTSS knockdown suppressed proliferation and migration/invasion and promoted apoptosis, whereas CTSS overexpression enhanced malignant phenotypes in the examined PTC cell models. CTSS expression was associated with activation of the PI3K/AKT/mTOR pathway, and CTSS inhibition attenuated pathway activation and tumor growth. TCF4 bound the CTSS promoter, increased CTSS transcription, and TCF4 knockdown reduced CTSS expression and PI3K/AKT/mTOR pathway activity. These findings suggest that CTSS promotes malignant phenotypes in PTC and is associated with PI3K/AKT/mTOR activation, while TCF4 may contribute to CTSS transcriptional regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The Yancheng Clinical College of Xuzhou Medical University , Yancheng, China.
- Department of General Surgery, The First people's Hospital of Yancheng , Yancheng, China.
- Yancheng Key Laboratory of Molecular Epigenetics, Yancheng Medical Research Center of Nanjing University Medical School, The First People's Hospital of Yancheng , Yancheng, Jiangsu, China.
- School of Medicine, Tongji University , Shanghai, China.
ORCID-Profile: Guangjun Zhou
Zitieren
APA
Zhang, X., Zhou, S., Zhang, S., Sun, Y., Yuan, W., Xu, H., Zhang, C., Xu, A., Zhou, L., & Zhou, G. (2026). TCF4-driven cathepsin S promotes papillary thyroid carcinoma via PI3K/AKT/mTOR. Endocrine-Related Cancer. https://doi.org/10.1530/erc-25-0517
Vancouver
Zhang X, Zhou S, Zhang S, Sun Y, Yuan W, Xu H, et al. TCF4-driven cathepsin S promotes papillary thyroid carcinoma via PI3K/AKT/mTOR. Endocrine-Related Cancer. 2026. doi:10.1530/erc-25-0517
BibTeX
@article{Zhang2026,
author = {Zhang, Xinyi and Zhou, Shengyi and Zhang, Shuyi and Sun, Yizhou and Yuan, Wei and Xu, Hongjie and Zhang, Chengzhi and Xu, Andong and Zhou, Linsen and Zhou, Guangjun},
title = {TCF4-driven cathepsin S promotes papillary thyroid carcinoma via PI3K/AKT/mTOR},
journal = {Endocrine-Related Cancer},
year = {2026},
doi = {10.1530/erc-25-0517}
}
EUVIMED